|
22
|
78
|
4oxcA |
Crystal structure of xiap bir1 domain |
|
9
|
66
|
4ppeA |
Human rnf4 ring domain |
|
9
|
82
|
4p5oB |
Structure of an rbx1-ubc12~nedd8-cul1-dcn1 complex: a ring-e3-e2~ubiquitin-like protein-substrate intermediate trapped in action |
|
26
|
92
|
4orhC |
Crystal structure of rnf8 bound to the ubc13/mms2 heterodimer |
|
28
|
93
|
4ogvA |
Co-crystal structure of mdm2 with inhibitor compound 49 |
|
64
|
233
|
4nkgA |
Crystal structure of ssph1 lrr domain in complex pkn1 hr1b domain |
|
32
|
93
|
4oq3A |
Tetra-substituted imidazoles as a new class of inhibitors of the p53-mdm2 interaction |
|
76
|
177
|
4nqjA |
Structure of coiled-coil domain |
|
67
|
211
|
4ofbA |
Crystal structure of human brca1 brct in complex with nonphosphopeptide inhibitor |
|
28
|
92
|
4obaA |
Co-crystal structure of mdm2 with inhibitor compound 4 |
|
34
|
99
|
4ogtA |
Co-crystal structure of mdm2 with inhbitor compound 46 |
|
33
|
99
|
4odfA |
Co-crystal structure of mdm2 with inhibitor compound 47 |
|
33
|
100
|
4ognA |
Co-crystal structure of mdm2 with inhbitor compound 3 |
|
27
|
93
|
4oasA |
Co-crystal structure of mdm2 (17-111) in complex with compound 25 |
|
28
|
93
|
4occA |
Co-crystal structure of mdm2(17-111) in complex with compound 48 |
|
35
|
105
|
4odeA |
Co-crystal structure of mdm2 with inhibitor compound 4 |
|
65
|
236
|
4nkhA |
Crystal structure of ssph1 lrr domain |
|
25
|
94
|
4mtiA |
Crystal structure of ciap1 bir3 bound to t3258042 |
|
29
|
86
|
4lwtA |
The 1.6a crystal structure of humanized xenopus mdm2 with ro5027344 |
|
33
|
94
|
4mdnA |
Structure of a novel submicromolar mdm2 inhibitor |
|
22
|
85
|
4lwvA |
The 2.3a crystal structure of humanized xenopus mdm2 with ro5545353 |
|
21
|
78
|
4mtzA |
Structure of xiap-bir1 in complex with nf023 |
|
28
|
85
|
4lwuA |
The 1.14a crystal structure of humanized xenopus mdm2 with ro5499252 |
|
23
|
90
|
4mu7A |
Crystal structure of ciap1 bir3 bound to t3450325 |
|
27
|
60
|
4m3lA |
Crystal structure of the coiled coil domain of murf1 |
|
32
|
86
|
4mdqA |
Structure of a novel submicromolar mdm2 inhibitor |
|
76
|
171
|
4ltbA |
Coiled-coil domain of trim25 |
|
24
|
92
|
4lgeA |
Crystal structure of clap1 bir3 bound to t3261256 |
|
20
|
82
|
4kjuA |
Crystal structure of xiap-bir2 with a bound benzodiazepinone inhibitor. |
|
52
|
130
|
4kbqA |
Structure of the chip-tpr domain in complex with the hsc70 lid-tail domains |
|
83
|
310
|
4lg8A |
Crystal structure of prpf19 wd40 repeats |
|
25
|
103
|
4kmnA |
Structure of ciap1-bir3 and inhibitor |
|
18
|
121
|
4ladB |
Crystal structure of the ube2g2:ring-g2br complex |
|
20
|
83
|
4kjvA |
Crystal structure of xiap-bir2 with a bound spirocyclic benzoxazepinone inhibitor. |
|
32
|
149
|
4kngE |
Crystal structure of human lgr5-rspo1-rnf43 |
|
21
|
90
|
4lguA |
Crystal structure of clap1 bir3 bound to t3226692 |
|
23
|
98
|
4kmpA |
Structure of xiap-bir3 and inhibitor |
|
31
|
85
|
4ipfA |
The 1.7a crystal structure of humanized xenopus mdm2 with ro5045337 |
|
45
|
192
|
4i7cA |
Siah1 mutant bound to synthetic peptide (ace)klrpv(23p)mvrpwvr |
|
25
|
96
|
4hy0A |
Crystal structure of xiap bir3 with t3256336 |
|
21
|
83
|
4j44A |
Crystal structure of xiap-bir2 domain with aiav bound |
|
13
|
63
|
4ic3A |
Crystal structure of the f495l mutant xiap ring domain |
|
25
|
95
|
4hy5A |
Crystal structure of ciap1 bir3 bound to t3256336 |
|
25
|
85
|
4jv7A |
Co-crystal structure of mdm2 with inhibitor (2s,5r,6s)-2-benzyl-5,6-bis(4-bromophenyl)-4-methylmorpholin-3-one |
|
29
|
86
|
4j7eA |
The 1.63a crystal structure of humanized xenopus mdm2 with a nutlin fragment, ro5524529 |
|
45
|
192
|
4i7dA |
Siah1 bound to synthetic peptide (ace)klrpvamvrp(prk)vr |
|
27
|
93
|
4jvrA |
Co-crystal structure of mdm2 with inhibitor (2's,3r,4's,5'r)-n-(2-aminoethyl)-6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-2-oxo-1,2-dihydrospiro[indole-3,3'-pyrrolidine]-5'-carboxamide |
|
20
|
83
|
4j45A |
Crystal structure of xiap-bir2 domain with ataa bound |
|
29
|
92
|
4jwrA |
Co-crystal structure of mdm2 with inhibitor {(2s,5r,6s)-6-(3-chlorophenyl)-5-(4-chlorophenyl)-4-[(2s)-1-hydroxybutan-2-yl]-3-oxomorpholin-2-yl}acetic acid |
|
27
|
83
|
4jscA |
The 2.5a crystal structure of humanized xenopus mdm2 with ro5316533 - a pyrrolidine mdm2 inhibitor |
